Enrollment Completed for Phase 3 Pyruvate Dehydrogenase Complex Deficiency (PDCD) Clinical Trial
source: unsplash.com

Enrollment Completed for Phase 3 Pyruvate Dehydrogenase Complex Deficiency (PDCD) Clinical Trial

According to a story from PR Newswire, the pharmaceutical company Saol Therapeutics has recently announced that it has completed its enrollment goals for its phase 3 clinical trial. This trial…

Continue Reading Enrollment Completed for Phase 3 Pyruvate Dehydrogenase Complex Deficiency (PDCD) Clinical Trial
Combination Therapy for Hepatocellular Carcinoma Fails to Achieve Trial Endpoints
source: pixabay.com

Combination Therapy for Hepatocellular Carcinoma Fails to Achieve Trial Endpoints

According to a story from Market Watch, the drug companies Merch and Eisai recently announced an update on their phase 3 clinical trial. This clinical trial was evaluating a combination…

Continue Reading Combination Therapy for Hepatocellular Carcinoma Fails to Achieve Trial Endpoints

Feasibility and Safety of Anlotinib Monotherapy for Patients with Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A Real-World Exploratory Study

[Cancer Management and Research](cancer-management-and-research-journal) » [Volume 14](cancer-management-and-research-archive55-v1655) Feasibility and Safety of Anlotinib Monotherapy for Patients with Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A Real-World Exploratory Study Authors [Zhang S](author_profile.php?id=1654738)…

Continue Reading Feasibility and Safety of Anlotinib Monotherapy for Patients with Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A Real-World Exploratory Study
A New Collaboration will Support the Distribution of a Novel Therapy for Arginase 1 Deficiency in the Middle East and Europe
source: pixabay.com

A New Collaboration will Support the Distribution of a Novel Therapy for Arginase 1 Deficiency in the Middle East and Europe

Aeglea Biotherapeutics has just announced a new collaboration with Immedica to bring pegzilarginase to other countries outside of the United States. They have created a license and supply agreement to…

Continue Reading A New Collaboration will Support the Distribution of a Novel Therapy for Arginase 1 Deficiency in the Middle East and Europe